Inspire Medical Systems (INSP) Research & Development (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Research & Development data on file, last reported at $25.8 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 7.11% year-over-year to $25.8 million; the trailing twelve-month figure through Mar 2026 stood at $101.2 million (down 10.52% YoY), and the FY2025 full-year result was $103.2 million, down 9.61% from the prior year.
• Research & Development climbed to $25.8 million in Q1 2026, from $24.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $31.1 million in Q4 2023 to a low of $11.9 million in Q1 2022.
• A 5-year average of $25.2 million and a median of $26.1 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 118.36% in 2022 and dropped 17.78% in 2025, its largest moves.
• Tracing INSP's Research & Development over 5 years: stood at $21.2 million in 2022, then soared by 46.14% to $31.1 million in 2023, then dropped by 2.31% to $30.3 million in 2024, then decreased by 17.78% to $24.9 million in 2025, then gained by 3.54% to $25.8 million in 2026.
• Business Quant data shows INSP's Research & Development at $25.8 million in Q1 2026, $24.9 million in Q4 2025, and $24.2 million in Q3 2025.